Anti-Obesity Agents

"Anti-Obesity Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and serotoninergic drugs have been experimentally used in patients with non-insulin dependent diabetes mellitus (NIDDM) to treat obesity.

Descriptor ID	D019440
MeSH Number(s)	D27.505.954.427.140
Concept/Terms	Anti-Obesity Agents Anti-Obesity Agents Agents, Anti-Obesity Anti Obesity Agents Anti-Obesity Drugs Anti Obesity Drugs Drugs, Anti-Obesity Antiobesity Drugs Drugs, Antiobesity Antiobesity Agents Agents, Antiobesity Weight-Loss Agents Weight-Loss Agents Agents, Weight-Loss Weight Loss Agents Weight-Loss Drugs Drugs, Weight-Loss Weight Loss Drugs

Below are MeSH descriptors whose meaning is more general than "Anti-Obesity Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Central Nervous System Agents [D27.505.954.427]
Anti-Obesity Agents [D27.505.954.427.140]

Below are MeSH descriptors whose meaning is related to "Anti-Obesity Agents".

Below are MeSH descriptors whose meaning is more specific than "Anti-Obesity Agents".

Anti-Obesity Agents
Appetite Depressants

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Anti-Obesity Agents" by people in this website by year, and whether "Anti-Obesity Agents" was a major or minor topic of these publications.

Bar chart showing 13 publications over 10 distinct years, with a maximum of 2 publications in 2013 and 2017 and 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2007	1	0	1
2013	2	0	2
2015	1	0	1
2016	1	0	1
2017	2	0	2
2018	1	0	1
2019	2	0	2
2020	1	0	1
2024	0	1	1
2025	1	0	1

Below are the most recent publications written about "Anti-Obesity Agents" by people in Profiles.

Ke L, He W, Zong C, Wang T, Xiao J, Cao Y, Xiao H, Liu X. A novel peptide derived from Haematococcus pluvialis residue balanced lipid metabolism through NHR-49/PPARa and AAK-2/AMPK pathways in Caenorhabditis elegans. Biofactors. 2025 Mar-Apr; 51(2):e70017.

View in: PubMed
Coppenrath V, Mazyck B. Tirzepatide (Zepbound) for the Treatment of Obesity. Am Fam Physician. 2024 08; 110(2):199-200.

View in: PubMed
Tchang BG, Morrison C, Kim JT, Ahmed F, Chan KM, Alonso LC, Aronne LJ, Shukla AP. Weight Loss Outcomes With Telemedicine During COVID-19. Front Endocrinol (Lausanne). 2022; 13:793290.

View in: PubMed
DiNicolantonio JJ, Bhat AG, OKeefe J. Effects of spirulina on weight loss and blood lipids: a review. Open Heart. 2020; 7(1):e001003.

View in: PubMed
Farr OM, Upadhyay J, Rutagengwa C, DiPrisco B, Ranta Z, Adra A, Bapatla N, Douglas VP, Douglas KAA, Nolen-Doerr E, Mathew H, Mantzoros CS. Longer-term liraglutide administration at the highest dose approved for obesity increases reward-related orbitofrontal cortex activation in response to food cues: Implications for plateauing weight loss in response to anti-obesity therapies. Diabetes Obes Metab. 2019 11; 21(11):2459-2464.

View in: PubMed
Thomas DD, Waring ME, Ameli O, Reisman JI, Vimalananda VG. Patient Characteristics Associated with Receipt of Prescription Weight-Management Medications Among Veterans Participating in MOVE! Obesity (Silver Spring). 2019 07; 27(7):1168-1176.

View in: PubMed
Tuccinardi D, Farr OM, Upadhyay J, Oussaada SM, Mathew H, Paschou SA, Perakakis N, Koniaris A, Kelesidis T, Mantzoros CS. Lorcaserin treatment decreases body weight and reduces cardiometabolic risk factors in obese adults: A six-month, randomized, placebo-controlled, double-blind clinical trial. Diabetes Obes Metab. 2019 06; 21(6):1487-1492.

View in: PubMed
Carreira MC, Andrade S, Gonzalez-Izquierdo A, Amil M, Folgueira C, Monteiro MP, Sanz E, Crujeiras AB, Casanueva FF. Anti-obesity activity of OBEX is regulated by activation of thermogenesis and decreasing adiposity gain. Sci Rep. 2018 11 21; 8(1):17155.

View in: PubMed
Suk S, Kwon GT, Lee E, Jang WJ, Yang H, Kim JH, Thimmegowda NR, Chung MY, Kwon JY, Yang S, Kim JK, Park JHY, Lee KW. Gingerenone A, a polyphenol present in ginger, suppresses obesity and adipose tissue inflammation in high-fat diet-fed mice. Mol Nutr Food Res. 2017 Oct; 61(10).

View in: PubMed
Semla TP, Ruser C, Good CB, Yanovski SZ, Ames D, Copeland LA, Billington C, Ferguson UI, Aronne LJ, Wadden TA, Garvey WT, Apovian CM, Atkins D. Pharmacotherapy for Weight Management in the VHA. J Gen Intern Med. 2017 Apr; 32(Suppl 1):70-73.

View in: PubMed

People

Explore

Similar Concepts

Top Journals